Immutep IMMP
NASDAQ IMMP
$4.20 -0.34 (-7.51%)
As of: Oct 2, 2026 · 11:35 AM EDT

Immutep (IMMP) Capital Expenditures (2011 - 2017)

Updated

Immutep (IMMP) reported Capital Expenditures of -$65,920 for the year ended Jun 30, 2026, compared with -$29,312 a year earlier.

Analysis

Immutep (IMMP) Capital Expenditures (2011 - 2017) Analysis & Trends

Dating back to the year ended Jun 30, 2010, Immutep's Capital Expenditures record includes 17 years.

  • The figure for the year ended Jun 30, 2026 ranks as the lowest annual Capital Expenditures since the year ended Jun 30, 2014.
  • According to Business Quant data, Capital Expenditures came in at -$29,312 in the year ended Jun 30, 2025, -$19,253 in the year ended Jun 30, 2024, -$55,297 in the year ended Jun 30, 2023 and -$16,413 in the year ended Jun 30, 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.32 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 322.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 893.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -321.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -763.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 513.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 140.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 533.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 112.20 Mn
10 Immutep 33.95 Mn 33.95 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2017 -3,001.09
Jun 30, 2016 -15,104.30
Jun 30, 2011 -47,582.54
API Access

Immutep Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=IMMP&period=max&api_key=YOUR_API_KEY